Interleukin‐10 functions as an antiinflammatory cytokine in rheumatoid synovium
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective. Interleukin‐10 (IL‐10) is an antiinflammatory cytokine that has been shown to play a role in rheumatoid arthritis (RA). We therefore investigated the effects of IL‐10 on the function and phenotype of synovial fluid mononuclear cells (SFMC) derived from patients with RA. In addition, we studied the production of IL‐10 in rheumatoid joints, and the role of endogenous IL‐10 in the regulation of SFMC function. Methods. The presence of IL‐10 in rheumatoid joints was studied using IL‐10–specific enzyme‐linked immunosorbent assay (ELISA) and reverse transcriptase–polymerase chain reaction (RT‐PCR) techniques. The effects of recombinant human IL‐10 or neutralizing anti–IL‐10 monoclonal antibodies (MAbs) on both cytokine production and phenotype of SFMC were evaluated using cytokine‐specific ELISAs and flow cytometry. The effect of IL‐10 on proliferation of SFMC was determined by incorporation of tritiated thymidine. Results. IL‐10 was detected by ELISA in 22 of 23 SF samples, and was spontaneously produced by cultured SFMC. IL‐10 messenger RNA was detectable in all 8 SFMC samples, as determined by RT‐PCR. Neutralization of endogenously produced IL‐10 by anti–IL‐10 MAbs resulted in increased production of IL‐1β, tumor necrosis factor α (TNF α), and granulocyte–macrophage colony‐stimulating factor (GM‐CSF) by SFMC, and in enhanced proliferation of SFMC. In particular, the production of TNF α was dramatically increased by anti–IL‐10 MAbs. Moreover, the expression of HLA–DR molecules by SF macrophages was increased, and the expression of CD16 was decreased by anti–IL‐10 MAbs. In contrast, addition of recombinant IL‐10 significantly decreased the production of IL‐1β, TNF α, and GM‐CSF by SFMC, and decreased spontaneous and IL‐2–induced proliferation of SFMC. Finally, IL‐10 decreased HLA–DR expression and increased the expression of the Fcγ receptors, CD16 and CD64, by SF macrophages. Conclusion. These data indicate that endogenously produced IL‐10 functions as an immunoregulatory molecule in rheumatoid synovium. Importantly, exogenous IL‐10 has potent antiinflammatory effects on SFMC, suggesting that IL‐10 may be useful in the treatment of patients with RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Cited by
Crawley, E., Kay, R., Sillibourne, J., Patel, P., Hutchinson, I., & Woo, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1101::aid-anr6>3.0.co;2-y · Cited by 530
Cells of the synovium in rheumatoid arthritis. Macrophages
Kinne, R. W., Stuhlmüller, B., & Burmester, G.-R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2333 · Cited by 300
Identification of genetic risk factors for periodontitis and possible mechanisms of action
Loos, B. G., John, R. P., & Laine, M. L. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00806.x · Cited by 295
The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives
Fox, D. A. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400403 · Cited by 289
Cantagrel, A., Navaux, F., Loubet-Lescouli�, P., Nourhashemi, F., Enault, G., Abbal, M., Constantin, A., Laroche, M., & Mazi�res, B. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1093::aid-anr5>3.0.co;2-p · Cited by 264
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Isomäki, P., & Punnonen, J. (1997) · Annals of Medicine · doi:10.3109/07853899709007474 · Cited by 260
Self-citationAdenovirus-Mediated Transfer of Viral IL-10 Gene Inhibits Murine Collagen-Induced Arthritis
Apparailly, F., Verwaerde, C., Jacquet, C., Auriault, C., Sany, J., & Jorgensen, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5213 · Cited by 197
Current trends in biocompatibility testing
Kirkpatrick, C. J., Bittinger, F., Wagner, M., Köhler, H., van Kooten, T. G., Klein, C. L., & Otto, M. (1998) · Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine · doi:10.1243/0954411981533845 · Cited by 145
Johansson, A. C. M., Hansson, A.-S., Nandakumar, K. S., Bäcklund, J., & Holmdahl, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3505 · Cited by 96
Metadata
- Authors
- Isomäki, P., Luukkainen, R., Saario, R., Toivanen, P., & Punnonen, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-03
- Volume
- 39
- Issue
- 3
- Pages
- 386-395
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2007088223
- Cited by
- 146
- References
- 3
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.